U.S. market Closed. Opens in 1 day 4 hours 32 minutes

AUTL | Autolus Therapeutics plc Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-09-302017-09-302016-09-302015-09-30
Revenue1.70M6.19M2.33M242.00K2.91M1.05M1.69M1.21M94.11K
Cost of Revenue6.57M137.22M128.65M134.89M4.61M48.30M1.01M478.00KN/A
Gross Profit-4.87M-131.03M-126.32M-134.65M-1.70M-47.25M684.00K734.00K94.11K
Operating Expenses1.70M173.72M166.65M168.39M144.87M41.48M25.11M15.59M8.20M
Selling, General & Admin46.74M31.90M31.86M34.97M39.45M16.85M9.10M5.15M6.04M
Research & Development149.98M141.99M134.79M134.89M105.42M24.64M16.01M10.44M2.17M
Other Operating ExpensesN/A-166.00K-145.00K-1.47M4.51M3.97M-46.00K-26.00KN/A
Operating Income-195.03M-163.78M-164.21M-168.15M-137.86M-57.53M-23.42M-14.38M-8.11M
Other Expenses / Income-13.37M-9.42M109.22M1.89M2.95M6.91M38.00K49.00K7.93K
Before Tax Income-208.40M-173.21M-165.99M-166.26M-139.01M-36.33M-23.38M-14.33M-8.10M
Income Tax Expenses-19.00K-24.37M-23.89M-24.16M-15.16M-5.21M-3.65M-1.78M634.51K
Net Income-208.38M-148.84M-142.10M-142.09M-123.85M-31.11M-19.73M-12.55M-7.46M
Interest Expenses45.07M8.90M1.10MN/AN/A12.67KN/AN/AN/A
Basic Shares Outstanding173.94M94.99M72.08M51.56M43.07M31.56M13.78M13.78M13.78M
Diluted Shares Outstanding173.94M94.99M72.08M51.56M43.07M31.56M13.78M13.78M13.78M
EBITDA-156.77M-135.54M-132.01M-160.51M-134.40M-50.32M-22.41M-13.90M-4.47M
EBITDA Margin-9,232.63%-2,188.18%-5,665.49%-66,325.62%-4,621.63%-4,813.92%-1,323.63%-1,146.70%-4,749.84%
EBIT-163.34M-164.30M-164.88M-166.26M-139.01M-36.31M-23.38M-14.33M-6.83M
EBIT Margin-9,619.26%-2,652.57%-7,076.52%-68,701.24%-4,780.19%-3,473.88%-1,380.98%-1,182.10%-7,256.93%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-09-302017-09-302016-09-302015-09-30
An error has occurred. This application may no longer respond until reloaded. Reload 🗙